Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta (Q45146790)
Jump to navigation
Jump to search
scientific article published on 10 November 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta |
scientific article published on 10 November 2004 |
Statements
1 reference
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta (English)
1 reference
Allen J Taylor
1 reference
Lance E Sullenberger
1 reference
Hyun J Lee
1 reference
Jeannie K Lee
1 reference
Karen A Grace
1 reference
10 November 2004
1 reference
1 reference
Identifiers
1 reference